Thinking About Prescribing
The Psychology of Psychopharmacology With Diverse Youth and Families
Edited by Shashank V. Joshi, M.D., FAAP, DFAACAP, and Andrés S. Martin, M.D., M.P.H.
- 0 Pages
- ISBN 978-1-61537-388-8
- Item #37388
Our remedies are only largely as good as the way in which we dispense them.
That’s the central premise of Thinking About Prescribing, a new volume that encourages psychopharmacotherapists to view the prescribing of a medication to young patients not as the beginning of the end of a therapeutic conversation, but rather as the beginning of an ongoing alliance with youths and their parents or legal guardians.
The book makes the case for a partnership that doesn’t lean on psychiatric jargon or an encyclopedic list of side effects, but instead on measured candor, vulnerability, and—most importantly—time.
Thinking About Prescribing leverages the knowledge of more than two dozen experts as it tackles topics that include:
- Understanding the psychodynamics of medication use in adolescents with serious mental illness
- Engaging in psychoeducation with patients and their families
- Being cognizant of the synergistic role of pediatricians, advanced practice clinicians, other primary care providers, and psychotherapists
- Prescribing via telemedicine during the COVID-19 pandemic
- Working with diverse youth and their families
Many of the chapters feature key takeaways and conclusions that distill the most salient points and that aid in knowledge retention.
Rather than raise unrealistic expectations (two chapters acknowledge the reality of practicing when time and resources are scarce), the goal of this book is to help psychopharmacotherapists dispel any feelings of stigma, apprehension, or resignation their patients may have and to instead build a trusting therapeutic relationship.
- Prescriber, Prescribe Thyself (By Way of Introduction)
- Chapter 1: Think Again About Prescribing: The Psychology of Psychopharmacology
- Chapter 2: The Many Facets of Alliance: The Y-Model, Applied to Child, Adolescent, and Young Adult Psychopharmacotherapy
- Chapter 3: Psychodynamics of Medication Use in Youth with Serious Mental Illness
- Chapter 4: “What’s in It for Me?”: Adapting Evidence-Based Motivation and Therapy Techniques to Adolescent Psychiatry
- Chapter 5: Providing Psychoeducation in Pharmacotherapy
- Chapter 6: #KeepItReal: The Myth of the “Med Check” and the Realities of the Time-Limited Pharmacotherapy Visit
- Chapter 7: Pharmacotherapy or Psychopharmacotherapy: When Therapist and Pharmacologist Are Different People, or the Same Person
- Chapter 8: The Pharmacotherapeutic Role of the Pediatrician, Advanced Practice Clinician, and Other Primary Care Providers
- Chapter 9: The Pharmacotherapeutic Alliance in School Mental Health
- Chapter 10: When Time Is Tight and Stakes Are High: Pharmacotherapy, Alliances, and the Inpatient Unit
- Chapter 11: Telepsychiatry Goes Viral: Psychotherapeutic Aspects of Prescribing Via Telemedicine Amid COVID-19
- Chapter 12: Alliance Issues to Consider in Pharmacotherapy with Transition-Age Youth
- Chapter 13: The Pharmacotherapeutic Alliance When Working with Diverse Youth and Families
- Chapter 14: The Psychopharmacotherapeutic Alliance When Resources Are Limited
- Chapter 15: Building a Therapeutic Alliance in Psychopharmacology During Clinical Trials: Ethical and Practical Considerations
- Chapter 16: The Power of Placebo
- Chapter 17: The “Good Enough” Pediatric Pharmacotherapist: Practical Pointers in Six Parables
- Chapter 18: Teaching and Mentoring the Next Generation of Pediatric Psychopharmacotherapists
About the Authors
Shashank V. Joshi, M.D., is Professor of Psychiatry, Pediatrics, and Education at the Stanford University School of Medicine and Graduate School of Education, Director of School Mental Health at Lucile Packard Children’s Hospital, and a Faculty Advisor at the Center for Comparative Studies in Race and Ethnicity (CCSRE), in Stanford, California.
Andres S. Martin, M.D., M.P.H., is the Riva Ariella Ritvo Professor in the Child Study Center and Director of the Standardized Patient Program at the Teaching and Learning Center, Yale School of Medicine, in New Haven, Connecticut. He is Medical Director of the Children's Psychiatric Inpatient Service at Yale New Haven Health, in New Haven, Connecticut.